Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
John DiPersio, MD, PhD, Washington University, St. Louis, MO, outlines the next questions in CAR-based therapies as well as new approaches to improving the efficacy of CAR T-cells. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).